DENVER INVESTMENT ADVISORS LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 99 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$68,000
+4.6%
10,111
-10.2%
0.00%0.0%
Q3 2015$65,000
-31.6%
11,258
-3.3%
0.00%
-25.0%
Q2 2015$95,000
-21.5%
11,646
-21.4%
0.00%0.0%
Q1 2015$121,000
-12.9%
14,826
-2.1%
0.00%0.0%
Q4 2014$139,00015,1400.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders